Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Nerve Tissue Proteins (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nerve Tissue Proteins (immunology) < Nerve Tissue Proteins (metabolism) < Nerve Tissue Proteins (physiology)  Facettes :

List of bibliographic references indexed by Nerve Tissue Proteins (metabolism)

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
000406 (2014) Edward J. Wild ; Sarah J. TabriziTargets for future clinical trials in Huntington's disease: What's in the pipeline?
000546 (2014) Charlotte Delay [Canada] ; Cyntia Tremblay ; Elodie Brochu ; Sarah Paris-Robidas ; Vincent Emond ; Ali H. Rajput ; Alex Rajput ; Frédéric CalonIncreased LINGO1 in the cerebellum of essential tremor patients.
000556 (2014) Neil Aronin [États-Unis] ; Marian DifigliaHuntingtin-lowering strategies in Huntington's disease: antisense oligonucleotides, small RNAs, and gene editing.
000868 (2013) Ai Miyashiro ; Katsunobu Sugihara ; Toshitaka Kawarai ; Ryosuke Miyamoto ; Yuishin Izumi ; Hiroyuki Morino ; Hirofumi Maruyama ; Antonio Orlacchio ; Hideshi Kawakami ; Ryuji KajiOromandibular dystonia associated with SCA36.
000A15 (2013) Jovana Lubarda [Canada] ; Sarah E. Groleau ; Nancy Thomas ; Mark A. Ferro ; Ram K. Mishra ; Joseph P. GabrieleDysregulation of novel catecholamine-regulated protein 40 (CRP40) in Parkinson's disease patients.
000E47 (2012) Lili-Naz Hazrati [Canada] ; Janice C. Wong ; Clement Hamani ; Andres M. Lozano ; Yu-Yan Poon ; Jonathan O. Dostrovsky ; William D. Hutchison ; Cindy Zadikoff ; Elena MoroClinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation.
001332 (2011) Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni]The effect of drug treatment on neurogenesis in Parkinson's disease
001484 (2011) C. Warren Olanow [États-Unis] ; K. Mcnaught [États-Unis]Parkinson's disease, proteins, and prions: Milestones
001486 (2011) John N. Caviness [États-Unis] ; Lih-Fen Lue [États-Unis] ; Thomas G. Beach [États-Unis] ; Joseph G. Hentz [États-Unis] ; Charles H. Adler [États-Unis] ; Lucia Sue [États-Unis] ; Ramin Sadeghi [États-Unis] ; Erika Driver-Dunckley [États-Unis] ; Virgilio G. Evidente [États-Unis] ; Marwan N. Sabbagh [États-Unis] ; Holly A. Shill [États-Unis] ; Douglas G. Walker [États-Unis]Parkinson's disease, cortical dysfunction, and alpha‐synuclein
002187 (2009) José-Félix Martí-Mass [Espagne] ; Javier Ruiz-Martínez [Espagne] ; Maria J. Bola O [Espagne] ; Irune Ruiz [Espagne] ; Ana Gorostidi [Espagne] ; Fermin Moreno [Espagne] ; Isidre Ferrer [Espagne] ; Adolfo L Pez De Munain [Espagne]Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2
002412 (2009) Masato Kanazawa [Japon] ; Takayoshi Shimohata [Japon] ; Yasuko Toyoshima [Japon] ; Mari Tada [Japon] ; Akiyoshi Kakita [Japon] ; Takashi Morita [Japon] ; Tetsutaro Ozawa [Japon] ; Hitoshi Takahashi [Japon] ; Masatoyo Nishizawa [Japon]Cerebellar involvement in progressive supranuclear palsy: A clinicopathological study
002427 (2009) Martin Witt [Allemagne] ; Katja Bormann [Allemagne] ; Volker Gudziol [Allemagne] ; Kerstin Pehlke [Allemagne] ; Kathrin Barth [Allemagne] ; Amir Minovi [Allemagne] ; Antje H Hner [Allemagne] ; Heinz Reichmann [Allemagne] ; Thomas Hummel [Allemagne]Biopsies of olfactory epithelium in patients with Parkinson's disease
002445 (2009) Dominique Caparros-Lefebvre [France] ; Olivier Kerdraon [France] ; David Devos [France] ; C. M. Dhaenens [France] ; David Blum [France] ; C. A Maurage [France] ; André Delacourte [France] ; Bernard Sablonnière [France]Association of corticobasal degeneration and Huntington's disease: Can Tau aggregates protect Huntingtin toxicity?
002736 (2008) Chelsea Stamper [États-Unis] ; Andrew Siegel [États-Unis] ; Winnie S. Liang [États-Unis] ; John V. Pearson [États-Unis] ; Dietrich A. Stephan [États-Unis] ; Holly Shill [États-Unis] ; Don Connor [États-Unis] ; John N. Caviness [États-Unis] ; Marwan Sabbagh [États-Unis] ; Thomas G. Beach [États-Unis] ; Charles H. Adler [États-Unis] ; Travis Dunckley [États-Unis]Neuronal gene expression correlates of Parkinson's disease with dementia
002D22 (2007) Katie Kompoliti [États-Unis] ; Yaping Chu [États-Unis] ; Kathleen M. Shannon [États-Unis] ; Jeffrey H. Kordower [États-Unis]Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient
002E17 (2007) Nadia Stefanova [Autriche] ; Martin Köllensperger [Autriche] ; Monika Hainzer [Autriche] ; Angela Cenci [Suède] ; Werner Poewe [Autriche] ; Gregor Karl Wenning [Autriche]High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence
003709 (2005) Paul Morrish [Royaume-Uni]The meaning of negative DAT SPECT and F‐Dopa PET scans in patients with clinical Parkinson's disease
003808 (2005) Yue Huang [Australie] ; Raymond Garrick [Australie] ; Raymond Cook [Australie] ; Dudley O'Sullivan [Australie] ; John Morris [Australie] ; Glenda M. Halliday [Australie]Pallidal stimulation reduces treatment‐induced dyskinesias in “minimal‐change” multiple system atrophy
003848 (2005) Carsten Saft [Allemagne] ; Jochen Zange [Allemagne] ; Jürgen Andrich [Allemagne] ; Klaus Müller [Allemagne] ; Katrin Lindenberg [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Matthias Vorgerd [Allemagne] ; Peter H. Kraus [Allemagne] ; Horst Przuntek [Allemagne] ; Ludger Schöls [Allemagne]Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease
003948 (2005) Michelle Porritt [Australie] ; Davor Stanic [Australie] ; David Finkelstein [Australie] ; Peter Batchelor [Australie] ; Sharon Lockhart [Australie] ; Andrew Hughes [Australie] ; Renate Kalnins [Australie] ; David Howells [Australie]Dopaminergic innervation of the human striatum in Parkinson's disease
003988 (2005) J. Eric Ahlskog [États-Unis]Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Nerve Tissue Proteins (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Nerve Tissue Proteins (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Nerve Tissue Proteins (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024